Figure 2

Role of novel cardiac biomarkers for the diagnosis, risk stratification, and prognostication among patients with heart failure

Jennifer Miao, Joel Estis, Yan Ru Su, John A Todd and Daniel J Lenihan*

Published: 22 August, 2019 | Volume 4 - Issue 2 | Pages: 103-109

jccm-aid1049-g002

Figure 2:

Kaplan-Meier survival curves based on combined risk stratification for NTproBNP, cTnI, and IL-6 using dichotimized median cutoff points. Patients with elevated levels of all three biomarkers had significantly higher risk of adverse events compared to those with any one of the biomarkers elevated and those with biomarker concentrations below the median cutoff.

Read Full Article HTML DOI: 10.29328/journal.jccm.1001049 Cite this Article Read Full Article PDF

More Images

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?